Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo
Loading...
Date
Advisors/Reviewers
Further Contributors
Contributing Institutions
Publisher
Journal Title
Journal ISSN
Volume Title
Publisher
License
Quotable link
DOI:
http://dx.doi.org/10.22029/jlupub-6068Link to publications or other datasets
Description
Notes
Original publication in
International journal of molecular sciences 23 (2022), 1 - 14, 6512